ABCL

ABCELLERA BIOLOGICS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

ABCELLERA BIOLOGICS INC (ABCL) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$299.65M; the largest are Baker Bros. Advisors, Paul Tudor Jones, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 2 added, 3 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Cooling

Common-stock holders51 also report options

Congress trades0

Price$14.82vs quarter-end+88.79%

Sectors0

This quarter's moves

New0

Added2

Trimmed / sold4

Top holderBaker Bros. Advisors

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Investor	Period	Value	Shares	% of portfolio	Action

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinCALL—

Value $6.20M— of portfolio790,3002026 Q2

Ken GriffinPUT—

Value $2.92M— of portfolio372,3002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinCALL	2026 Q2	$6.20M	790,300	—	—
Ken GriffinPUT	2026 Q2	$2.92M	372,300	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.